Part Number
Part Number:
NSN:
NIIN:
Item Name:
PYRIDOSTIGMINE BROMIDE TABLETS , U
Definition:
CAGE Information
| Code | Company |
|---|---|
| 53702 | VALEANT CANADA LTD |
Federal Supply Class
Title
DRUGS AND BIOLOGICALS
Inclusions:
INCLUDES ALL DRUGS, MEDICINAL GRADE CHEMICALS, AND BIOLOGICALS SUBJECT TO THE FEDERAL FOOD, DRUG AND COSMETIC ACT, LISTED IN THE MONOGRAPH SECTION OF THE U.S. PHARMACOPEIA OR THE NATIONAL FORMULARY OR COVERED BY THE UNITED STATES ADOPTED NAMES (USAN). OTHER NATIONS MAY APPLY THEIR OWN LEGAL DOCUMENTS.
Exclusions:
EXCLUDES MEDICATED COSMETICS AND TOILETRIES CLASSIFIABLE IN FSC 6508 AND IN VITRO DIAGNOSTIC SUBSTANCES AND REAGENTS CLASSIFIABLE IN FSC 6550, AND VETERINARY DRUGS AND BIOLOGICALS CLASSIFIABLE IN FSC 6509.
Characteristics (Decoded)
| MRC | Requirements Statement | Clear Text Reply |
|---|---|---|
| FEAT | SPECIAL FEATURES | BLISTER OR STRIP PACKAGE; TEN PACKAGES, EACH PACKAGE CONTAINS 21 TABLETS PACKED IN A SEALED BAG; THE BLISTER OR STRIP PACKAGE IS CONTAINED IN A CRUSH PROOF PLASTIC SLEEVE; TOTAL QUANTITY 210 TABLETS; FOR USE IN NERVE AGENT PRE-TREATMENT STORE AND SHIP AT 2 TO 8 DEGREES C |
| CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 10 |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 30.000 MILLIGRAMS PYRIDOSTIGMINE BROMIDE ACTIVE INGREDIENT |
| SUPP | SUPPLEMENTARY FEATURES | REQUIRES REFRIG BTWN 2-8 DEG C |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 21.000 TABLETS |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | PYRIDOSTIGMINE BROMIDE TABLETS USP 30MG I.S. 210S PG |
| CRXL | PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER | 10 STRIP |
| CBBL | FEATURES PROVIDED | INDIVIDUALLY SEALED |
| CSCX | TOTAL SECONDARY CONTAINER QUANTITY | 10 |